JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
Silicon Laboratories
SLAB
$7.42B
| $9.96M | ﹤0.01% |
112,732
+31,710
| +39% | +$2.85M |
2015 Q4
8 quarters
|
|
|
ILG
2052
DELISTED
ILG, Inc Common Stock
ILG
| $9.95M | ﹤0.01% |
349,472
-635,086
| -65% | -$18.3M |
2015 Q4
8 quarters
|
|
2053
Churchill Downs
CHDN
$5.21B
| $9.92M | ﹤0.01% |
255,834
+42,348
| +20% | +$1.53M |
2013 Q2
18 quarters
|
|
2054
ScottsMiracle-Gro
SMG
$2.91B
| $9.91M | ﹤0.01% |
92,655
-17,142
| -16% | -$1.71M |
2013 Q2
18 quarters
|
|
2055
PUT
Tyson Foods
TSN
$17.8B
| $9.87M | ﹤0.01% |
121,800
+51,800
| +74% | +$3.96M |
2017 Q3
1 quarter
|
|
2056
Enterprise Financial Services Corp
EFSC
$2.15B
| $9.86M | ﹤0.01% |
218,375
-9,752
| -4% | -$427K |
2013 Q2
18 quarters
|
|
|
ALEX
2057
DELISTED
Alexander & Baldwin
ALEX
| $9.85M | ﹤0.01% |
355,041
+48,207
| +16% | +$1.88M |
2013 Q2
18 quarters
|
|
2058
Macerich
MAC
$6.39B
| $9.82M | ﹤0.01% |
149,570
-1,299,479
| -90% | -$79.5M |
2013 Q2
18 quarters
|
|
|
ARA
2059
DELISTED
American Renal Associates Holdings, Inc
ARA
| $9.8M | ﹤0.01% |
563,362
+492,512
| +695% | +$6.8M |
2016 Q2
6 quarters
|
|
2060
CALL
Coca-Cola
KO
$370B
| $9.77M | ﹤0.01% |
212,900
-22,100
| -9% | -$1.02M |
2014 Q3
13 quarters
|
|
2061
NETGEAR
NTGR
$622M
| $9.77M | ﹤0.01% |
166,257
+141,340
| +567% | +$7.24M |
2013 Q2
18 quarters
|
|
2062
Enanta Pharmaceuticals
ENTA
$374M
| $9.76M | ﹤0.01% |
166,287
+50,310
| +43% | +$2.52M |
2016 Q1
7 quarters
|
|
2063
Sprouts Farmers Market
SFM
$6.01B
| $9.74M | ﹤0.01% |
399,885
-319,606
| -44% | -$6.77M |
2014 Q2
14 quarters
|
|
|
STAY
2064
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $9.73M | ﹤0.01% |
511,880
+80,967
| +19% | +$1.51M |
2014 Q3
13 quarters
|
|
2065
Hovnanian Enterprises
HOV
$685M
| $9.72M | ﹤0.01% |
116,016
+99,668
| +610% | +$6.17M |
2015 Q4
8 quarters
|
|
|
SUNS
2066
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $9.7M | ﹤0.01% |
546,155
+3,179
| +0.6% | +$56.7K |
2013 Q2
18 quarters
|
|
2067
Shake Shack
SHAK
$2.43B
| $9.69M | ﹤0.01% |
224,192
+210,769
| +1,570% | +$8.17M |
2015 Q3
9 quarters
|
|
2068
CALL
HCA Healthcare
HCA
$91.7B
| $9.65M | ﹤0.01% |
109,900
| – | – |
2017 Q2
2 quarters
|
|
2069
Home BancShares
HOMB
$5.71B
| $9.62M | ﹤0.01% |
413,551
-26,105
| -6% | -$610K |
2013 Q2
18 quarters
|
|
2070
Myriad Genetics
MYGN
$388M
| $9.61M | ﹤0.01% |
279,857
-17,215
| -6% | -$581K |
2013 Q2
18 quarters
|
|
|
SEM
2071
DELISTED
Select Medical
SEM
| $9.6M | ﹤0.01% |
1,008,992
-15,659
| -2% | -$150K |
2015 Q2
10 quarters
|
|
2072
Icon
ICLR
$12.5B
| $9.59M | ﹤0.01% |
85,481
+43,438
| +103% | +$5.01M |
2014 Q4
12 quarters
|
|
|
CHSP
2073
DELISTED
Chesapeake Lodging Trust
CHSP
| $9.58M | ﹤0.01% |
353,650
-24,337
| -6% | -$683K |
2013 Q2
18 quarters
|
|
2074
Commercial Metals
CMC
$6.94B
| $9.57M | ﹤0.01% |
448,779
-96,655
| -18% | -$1.92M |
2013 Q2
18 quarters
|
|
2075
Independent Bank Corp
IBCP
$790M
| $9.5M | ﹤0.01% |
425,062
+6,520
| +2% | +$147K |
2015 Q3
9 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.